Drug Chatter -- Tracking biopharma stock chatter

Profile for Heron Therapeutics, Inc. (HRTX)

« Back to company index

HRTX Chatter Timeline

Stock Ticker for HRTX

Most Active Tweeters for HRTX

UserTweets
@stocknewstimes 14
@ConsumerFeed 13
@AmericanBanking 12
@SleekMoneycom 10
@1MinuteStock 9

Recent Tweets for HRTX

dispatchtribune @dispatchtribune
Heron Therapeutics’ $HRTX “Buy” Rating Reiterated at Cantor Fitzgerald https://t.co/OsGuxyN1tI
November 20th 2017, 3:11am
SleekMoneycom @SleekMoneycom
Heron Therapeutics, Inc. $HRTX Receives “Buy” Rating from Mizuho https://t.co/IT72SK8WoQ
November 19th 2017, 9:11pm
stocknewstimes @stocknewstimes
Heron Therapeutics, Inc. $HRTX Receives “Buy” Rating from Mizuho https://t.co/ejEHgkSPfC
November 19th 2017, 8:11pm
IRAMarketReport @IRAMarketReport
Heron Therapeutics $HRTX Getting Somewhat Favorable Media Coverage, Accern Reports https://t.co/w0u83kEpqD
November 19th 2017, 9:11am
chaffeybreeze @chaffeybreeze
Heron Therapeutics $HRTX Getting Somewhat Favorable Media Coverage, Accern Reports https://t.co/v1M0ntVy5N
November 19th 2017, 9:11am
stocknewstimes @stocknewstimes
New York State Common Retirement Fund Has $673,000 Position in Heron Therapeutics, Inc. $HRTX https://t.co/E7qcAnNvyI
November 19th 2017, 9:11am
dispatchtribune @dispatchtribune
FY2017 Earnings Estimate for Heron Therapeutics, Inc. Issued By Cantor Fitzgerald $HRTX https://t.co/xam50o5TnT
November 19th 2017, 8:11am
SleekMoneycom @SleekMoneycom
Heron Therapeutics, Inc. $HRTX Upgraded by Zacks Investment Research to “Hold” https://t.co/wfcx9qy2lH
November 19th 2017, 7:11am
ledgerzette @ledgerzette
Heron Therapeutics, Inc. $HRTX Receives Buy Rating from Cantor Fitzgerald https://t.co/JSj8GjfkeH
November 18th 2017, 2:11am
ledgerzette @ledgerzette
Heron Therapeutics, Inc. $HRTX Receives “Buy” Rating from Mizuho https://t.co/TQ3fAIGUbb
November 17th 2017, 6:11pm
TopTickrs @TopTickrs
RT @ledgerzette: Heron Therapeutics, Inc. $HRTX Posts Quarterly Earnings Results, Beats Estimates By $0.10 EPS https://t.co/WQmbXUqMAO
November 17th 2017, 3:11pm
ledgerzette @ledgerzette
Heron Therapeutics, Inc. $HRTX Posts Quarterly Earnings Results, Beats Estimates By $0.10 EPS https://t.co/WQmbXUqMAO
November 17th 2017, 3:11pm
MilianInvesting @MilianInvesting
$HRTX & $AKCA both looking good on volume. Huge upside in both, any dips are buys at this point.
November 17th 2017, 12:11pm
dispatchtribune @dispatchtribune
Heron Therapeutics, Inc. $HRTX Issues Earnings Results https://t.co/0DTdoKOjKQ
November 16th 2017, 4:11pm
BOYWONDERELROY @BOYWONDERELROY
RT @WeekHerald: Heron Therapeutics, Inc. $HRTX Releases Quarterly Earnings Results, Beats Estimates By $0.10 EPS https://t.co/zJKfaPrjft
November 16th 2017, 4:11pm
WeekHerald @WeekHerald
Heron Therapeutics, Inc. $HRTX Releases Quarterly Earnings Results, Beats Estimates By $0.10 EPS https://t.co/zJKfaPrjft
November 16th 2017, 3:11pm
stocknewstimes @stocknewstimes
Heron Therapeutics, Inc. $HRTX Issues Earnings Results https://t.co/7AYOcDMpLO
November 16th 2017, 2:11pm
bret_jensen @bret_jensen
#biotech $HRTX Revisiting Heron Therapeutics After Friday's FDA Approval https://t.co/VYiDcpqNvW
November 16th 2017, 11:11am
ZolmaxNews @ZolmaxNews
Heron Therapeutics, Inc. $HRTX Stake Maintained by California Public Employees Retirement System https://t.co/Ihx9HoADlB
November 16th 2017, 5:11am
dailymailtimes @dailymailtimes
Heron Therapeutics, Inc. $HRTX Earns “Buy” Rating from Noble Financial https://t.co/W2JHggXP0f
November 16th 2017, 1:11am
WKRBNews @WKRBNews
Heron Therapeutics, Inc. $HRTX Earns “Buy” Rating from Noble Financial https://t.co/Is5n0JJY8i
November 16th 2017, 1:11am
dailypoliticaln @dailypoliticaln
Heron Therapeutics, Inc. $HRTX Earns “Buy” Rating from Noble Financial https://t.co/OQ93SvyAml
November 16th 2017, 1:11am
midetimes @midetimes
Heron Therapeutics, Inc. $HRTX Earns “Buy” Rating from Noble Financial https://t.co/jH3zWFgvf4
November 16th 2017, 1:11am
stocknewstimes @stocknewstimes
Cowen and Company Reiterates Buy Rating for Heron Therapeutics, Inc. $HRTX https://t.co/2rf027KEnR
November 15th 2017, 11:11pm
IRAMarketReport @IRAMarketReport
Brokers Offer Predictions for Heron Therapeutics, Inc.’s FY2020 Earnings $HRTX https://t.co/42BY9X2gg3
November 15th 2017, 5:11pm
chaffeybreeze @chaffeybreeze
Brokers Offer Predictions for Heron Therapeutics, Inc.’s FY2020 Earnings $HRTX https://t.co/xBwghuU9Vq
November 15th 2017, 5:11pm
TheMarketsDaily @TheMarketsDaily
Heron Therapeutics, Inc. $HRTX Shares Gap Down to $17.35 https://t.co/gN0tcd38q2
November 15th 2017, 12:11pm
bkfViking123 @bkfViking123
$hrtx off the lows
November 15th 2017, 10:11am
intercooleronli @intercooleronli
Recent Analysts’ Ratings Changes for Heron Therapeutics $HRTX https://t.co/eKOgcPJdsi
November 15th 2017, 9:11am
AmericanBanking @AmericanBanking
Recent Analysts’ Ratings Changes for Heron Therapeutics $HRTX https://t.co/hLWUM8Frpf
November 15th 2017, 9:11am
ConsumerFeed @ConsumerFeed
Recent Analysts’ Ratings Changes for Heron Therapeutics $HRTX https://t.co/UgR0NBygMY #acn
November 15th 2017, 9:11am
CFinancialNews @CFinancialNews
Recent Analysts’ Ratings Changes for Heron Therapeutics $HRTX https://t.co/ioEM5FFHXZ
November 15th 2017, 9:11am
TheMarketsDaily @TheMarketsDaily
Recent Analysts’ Ratings Changes for Heron Therapeutics $HRTX https://t.co/KN74AjxMHB
November 15th 2017, 9:11am
CBPartners @CBPartners
Injectable emulsion $HRTX CINVANTI wins #FDA approval as preventative treatment for acute and delayed #CINV… https://t.co/LkSqUmmlZN
November 14th 2017, 8:11pm
stocknewstimes @stocknewstimes
Short Interest in Heron Therapeutics, Inc. $HRTX Drops By 11.2% https://t.co/MdZVDRutaE
November 14th 2017, 7:11pm
SleekMoneycom @SleekMoneycom
Short Interest in Heron Therapeutics, Inc. $HRTX Drops By 11.2% https://t.co/ycrVghCmNS
November 14th 2017, 7:11pm
TheMarketsDaily @TheMarketsDaily
FY2020 EPS Estimates for Heron Therapeutics, Inc. $HRTX Decreased by Analyst https://t.co/rytbHIV0CF
November 14th 2017, 2:11pm
SleekMoneycom @SleekMoneycom
Cantor Fitzgerald Reaffirms Buy Rating for Heron Therapeutics, Inc. $HRTX https://t.co/kD8nGfxLSE
November 14th 2017, 2:11pm
tymorapro @tymorapro
$HRTX: At/Below 200DaySMA[+15.03]:11d, cl:-9, 2NearLo, AtPivS2, tf:1000010, ch:-4.7%, medFlt:35M, HiPctSht[40%:8d]; TLM:1.3;
November 14th 2017, 1:11pm
ConsumerFeed @ConsumerFeed
Heron Therapeutics’ $HRTX “Buy” Rating Reaffirmed at Oppenheimer Holdings, Inc. https://t.co/5I5MhmdAmX
November 14th 2017, 12:11pm
dakotafinancial @dakotafinancial
Heron Therapeutics’ $HRTX “Buy” Rating Reaffirmed at Oppenheimer Holdings, Inc. https://t.co/SOsruuyfgs
November 14th 2017, 12:11pm
tymorapro @tymorapro
$HRTX: At/Above 200DaySMA[+15.03]:11d, cl:-9, 0NearLo, tf:1000001, ch:-4.9%, medFlt:35M, HiPctSht[40%:8d]; TLM:0.7; cl-op-; rv:-1.02
November 14th 2017, 12:11pm
ledgerzette @ledgerzette
Heron Therapeutics, Inc. $HRTX Stake Lowered by Fox Run Management L.L.C. https://t.co/1ANn01qDv4
November 14th 2017, 8:11am
stocknewstimes @stocknewstimes
Cantor Fitzgerald Analysts Give Heron Therapeutics, Inc. $HRTX a $31.00 Price Target https://t.co/6qUlVRXx4B
November 14th 2017, 6:11am
SleekMoneycom @SleekMoneycom
Cantor Fitzgerald Analysts Give Heron Therapeutics, Inc. $HRTX a $31.00 Price Target https://t.co/wxAQlR3wdy
November 14th 2017, 6:11am
ZolmaxNews @ZolmaxNews
Noble Financial Reiterates Buy Rating for Heron Therapeutics, Inc. $HRTX https://t.co/3jQ3WdMo8u
November 14th 2017, 2:11am
WeekHerald @WeekHerald
Heron Therapeutics’ $HRTX Buy Rating Reiterated at Oppenheimer Holdings, Inc. https://t.co/EHSOnd5g3i
November 14th 2017, 12:11am
dispatchtribune @dispatchtribune
Heron Therapeutics, Inc. $HRTX Given “Buy” Rating at Oppenheimer Holdings, Inc. https://t.co/HAoaPuJgJr
November 13th 2017, 9:11pm
ZolmaxNews @ZolmaxNews
Heron Therapeutics, Inc. $HRTX Stock Rating Reaffirmed by Oppenheimer Holdings, Inc. https://t.co/XVVT5FjPlT
November 13th 2017, 9:11pm
TheMarketsDaily @TheMarketsDaily
Heron Therapeutics, Inc. $HRTX Given “Buy” Rating at Oppenheimer Holdings, Inc. https://t.co/R8FcrXOceR
November 13th 2017, 9:11pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.